Outcomes of Thoracic Endovascular Aneurysm Repair (TEVAR) in Patients With Connective Tissue Disorders

Abstract

Objectives:

Thoracic endovascular aortic repair (TEVAR) remains controversial in patients with connective tissue disorders given the concern for durability. We report on the largest series to date on outcomes of patients with thoracic aortic disease and connective tissue disorders treated with TEVAR.

Methods:

The Vascular Quality Initiative registry identified 12 207 patients treated with TEVAR from January 2010 to December 2018, including 102 with Marfans, Ehlers-Danlos, or Loey-Dietz syndrome. Outcomes were analyzed per the Society for Vascular Surgery reporting standards.

Results:

Median age was 50.6 years (interquartile range: 57.0-75.0), and 62 (60.7%) were male. Eighty-eight (86.3%) patients had Marfan, 9 (8.8%) had Ehlers-Danlos, and 5 (4.9%) had Loey-Dietz syndrome. Twenty-six (25.5%) patients were treated for degenerative aneurysmal disease and 76 (74.5%) patients for type B dissections (33 acute, 31 chronic). Most common indications for interventions in patients with type B dissection were pain (n = 41), aneurysmal degeneration (n = 16), and malperfusion (n = 8), with 3 patients who presented ruptured. There was no significant difference in perioperative complications between acute/chronic dissections and aneurysms (P = .14). Percutaneous access was utilized in 61.7% of patients, with a 2.9% rate of arterial injury requiring reintervention. Follow-up data were available for 75 (73.3%) patients at a mean follow-up of 15.6 months. Overall mortality was 5.3%. There were 30 patients with follow-up endoleak data, and 8 (26.7%) endoleaks were identified. All endoleaks were in patients treated for acute type B dissection, and all resolved after a mean of 2.1 reinterventions. Three patients treated for acute Type B Aortic Dissection (TBAD) had retrograde dissections requiring intervention.

Discussion:

Thoracic endovascular aortic repair for patients with connective tissue disorders can be performed with low perioperative mortality, spinal cord ischemia, or Cerebrovascular Accident (CVA). On follow-up, acute type B aortic dissections represent a higher risk subgroup with increased rates of endoleak and retrograde dissection. Closer follow-up for these patients and early reintervention may be beneficial.

Keywords

TEVAR thoracic aneurysm Marfan syndrome

Get full access to this article

View all access options for this article.

References

Cury

Zeidan

Lobato

. Aortic disease in the young: genetic aneurysm syndromes, connective tissue disorders, and familial aortic aneurysms and dissections. Int J Vasc Med. 2013;2013:267215. doi:10.1155/2013/267215

Judge

Dietz

. Marfan’s syndrome. Lancet. 2005;366(9501):1965–1976.

Böckler

Meisenbacher

Peters

Grond-Ginsbach

Bischoff

. Endovascular treatment of genetically linked aortic diseases Endovaskuläre Therapie genetisch bedingter Aortenerkrankungen. Gefässchirurgie. 2017;22(S1):1–7. doi:10.1007/s00772-016-0221-z

Oderich

Panneton

Bower

, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2005;42(1):98–106. doi:10.1016/j.jvs.2005.03.053

Pepin

Schwarze

Superti-Furga

Byers

. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342(10):673–680. doi:10.1056/NEJM200003093421001

Loeys

Schwarze

Holm

, et al. Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med. 2006;355(8):788–798. doi:10.1056/NEJMoa055695

Harky

Kai Chan

Ming Wong

Bashir

. Open versus endovascular repair of descending thoracic aortic aneurysm disease: a systematic review and meta-analysis. Ann Vasc Surg. 2019;54:304–315.e5. doi:10.1016/j.avsg.2018.05.043

Arnaoutakis

Abularrage

, et al. Comparison of thoracic endovascular aortic repair with open thoracic aortic repair using modern end-organ preservation strategies. Ann Vasc Surg. 2015;29(5):882–890. doi:10.1126/science.1249098.Sleep

Harky

Iqbal

Giordano

Al-Adhami

. Aortic endovascular stenting in patients with systemic connective tissue disorders: does the prohibitive dogma still stand tall? J Int Med Res. 2019:030006051986396. doi:10.1177/0300060519863963

10.

Cheng

Martin

Shennib

, et al. Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease. a systematic review and meta-analysis of comparative studies. J Am Coll Cardiol. 2010;55(10):986–1001. doi:10.1016/j.jacc.2009.11.047

11.

Ranney

Cox

Yerokun

Benrashid

McCann

Hughes

. Long-term results of endovascular repair for descending thoracic aortic aneurysms. J Vasc Surg. 2018;67(2):363–368. doi:10.1016/j.jvs.2017.06.094

12.

Hicks

Lue

Glebova

Ehlert

Black

. A 10-year institutional experience with open branched graft reconstruction of aortic aneurysms in connective tissue disorders versus degenerative disease. J Vasc Surg. 2017;66(5):1406–1416. doi:10.1016/j.jvs.2017.03.451

13.

Tjaden

Azizzadeh

. Endovascular therapy in Marfan syndrome: PRO. Ann Cardiothorac Surg. 2017;6(6):672–676. doi:10.21037/acs.2017.10.06

14.

Botta

Russo

La Palombara

Rosati

Di Bartolomeo

Fattori

. Stent graft repair of descending aortic dissection in patients with Marfan syndrome: an effective alternative to open reoperation? J Thorac Cardiovasc Surg. 2009;138(5):1108–1114. doi:10.1016/j.jtcvs.2009.03.014

15.

Geisbüsch

Kotelis

Von Tengg-Kobligk

Hyhlik-Dürr

Allenberg

Böckler

. Thoracic aortic endografting in patients with connective tissue diseases. J Endovasc Ther. 2008;15(2):144–149. doi:10.1583/07-2286.1

16.

Elefteriades

JA.

Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg. 2002;74(5):S1877–S1880. doi:10.1016/S0003-4975(02)04147-4

17.

Nordon

Hinchliffe

Holt

, et al. Endovascular management of chronic aortic dissection in patients with Marfan syndrome. J Vasc Surg. 2009;50(5):987–991. doi:10.1016/j.jvs.2009.05.056

18.

Eid-Lidt

Gaspar

Meléndez-Ramírez

, et al. Endovascular treatment of type B dissection in patients with marfan syndrome: Mid-term outcomes and aortic remodeling. Catheter Cardiovasc Interv. 2013;82(7):E898–E905. doi:10.1002/ccd.24725

19.

Pacini

Parolari

Berretta

Di Bartolomeo

Alamanni

Bavaria

. Endovascular treatment for type B dissection in Marfan syndrome: is it worthwhile? Ann Thorac Surg. 2013;95(2):737–749. doi:10.1016/j.athoracsur.2012.09.059

20.

Khalique

Lyons

OTA

Clough

, et al. Successful endovascular repair of acute type B aortic dissection in undiagnosed ehlers-danlos syndrome type IV. Eur J Vasc Endovasc Surg. 2009;38(5):608–609. doi:10.1016/j.ejvs.2009.07.009

21.

Kalra

Harris

Kische

Alden

Schumacher

Nienaber

. Endovascular repair of descending thoracic aorta in Loeys-Dietz II syndrome. Ann Vasc Surg. 2015;29(7):1452.e17–1452.e21. doi:10.1016/j.avsg.2015.04.071

22.

Dong

Wang

. Retrograde type A aortic dissection after endovascular stent graft placement for treatment of type B dissection. Circulation. 2009;119(5):735–741. doi:10.1161/CIRCULATIONAHA.107.759076

23.

Chen

Zhang

Liu

Zhang

Jing

. Retrograde type a aortic dissection after thoracic endovascular aortic repair: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6(9):e004649. doi:10.1161/JAHA.116.004649